Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain-Reference-Cited by-同舟云学术

Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain

Published:2008-07 Issue:5 Volume:19 Page:333-340
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Batlle Javier,Villar Ana,Liras Antonio,Alonso Concepción,Altisent Carmen,Brito Dilia,Moreno Manuel,Lucía Félix,Sedano Carmen,Prieto Manuel,Calvente Natividad,Aznar José A,Jiménez Víctor,Soriano Vicente,Martorell Javier R,Iruín Gemma,Bergua Juan M,Aguilar Carlos

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference44 articles.

1. The need for continuing vigilance: addressing the threat for transmission of blood-borne infectious disease;Stanley;Semin Hematol,2006

2. Consideration in hemophilia therapy selection;Pipe;Semin Hematol,2006

3. Current and emerging infectious risks of blood transfusions;Busch;JAMA,2003

4. Emerging infections, transfusion safety, and epidemiology;Dodd;N Engl J Med,2003

5. Safety and supply of haemophilia products: worldwide perspectives;Farruggia;Haemophilia,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults;BLOOD TRANSFUS-ITALY;2016

2. Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey;Haemophilia;2014-02-18

3. Jak wybrać koncentrat czynnika krzepnięcia dla dziecka chorego na hemofilię?;Acta Haematologica Polonica;2014-01

4. Clinical use of factor VIII and factor IX concentrates;BLOOD TRANSFUS-ITALY;2013

5. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain;Haemophilia;2013-06-11